Pranay Sinha MD, SM

Assistant Professor, Infectious Diseases

801 Massachusetts Ave | (617) 638-7578
Pranay Sinha
Sections

Infectious Diseases

Biography

I am an Assistant Professor of Medicine at the Boston University Chobanian & Avedisian School of Medicine and work as an Infectious Diseases physician at Boston Medical Center. I earned my medical degree from the University of Virginia and completed my residency in Internal Medicine at Yale-New Haven Hospital, where I graduated with a distinction in Global Health and Equity. I then pursued an Infectious Diseases fellowship at Boston University and also hold a Master’s degree in Health Policy and Management from Harvard University.

My work focuses on tuberculosis and infectious diseases, with a particular interest in how undernutrition affects TB outcomes in vulnerable populations. I am involved in research in India, Benin, and Togo, exploring ways to integrate social determinants into health interventions. I aim to promote cost-effective nutritional support that can improve health outcomes in settings with limited resources.

I co-founded and co-chair the TB-undernutrition Working Group at the International Union Against Tuberculosis and Lung Disease, a dynamic community of researchers, clinicians, and advocates who have contributed meaningfully to the recognition of undernutrition as an important TB comorbidity. Due to my engagement with TB-undernutrition research, I have served as a technical resource person for the World Health Organization. I have also collaborated with the governments of India, Benin, and Togo to expand nutritional support and anti-helminthic treatment for people with tuberculosis.

At Boston Medical Center, I’m fortunate to work alongside talented colleagues, and I am involved in training medical students, residents, and fellows. It has been a privilege to mentor more than thirty trainees along the way.

The modicum of success I have enjoyed in academic medicine is a product of guidance and support from a village of generous mentors. Now, I try to pay their kindness forward. I feel very privileged when a brilliant young trainee entrusts their growth as a physician or researcher to me.

Education

MD, University of Virginia School of Medicine

Health Policy Management, SM/ScM, Harvard School of Public Health

Biology, BS, Adelphi University

Publications

Published on 10/27/2025

Saunders MJ, Sinha P, Cegielski JP, Clark RA, Seddon JA, Martinez L, Bhargava M, Bhargava A, White RG, Houben RMGJ, McQuaid CF. Tuberculosis and undernutrition: improving estimates to reinforce the policy imperative. Lancet Infect Dis. 2025 Oct 27. PMID: 41167206.

Published on 10/15/2025

Kagemann CH, Prakash Babu S, Ezhumalai K, Chakraborty A, Raghupathy K, Kamat SS, Viswanathan V, Huey SL, Narasimhan PB, Sinha P, Yu EA, Mehta S, Sarkar S. Metabolite dynamics over the course of anti-tuberculosis treatment in individuals with mild and severe tuberculosis. PLOS Glob Public Health. 2025; 5(10):e0004925. PMID: 41091730.

Published on 9/22/2025

Carwile ME, Prakash Babu S, Cintron C, Dauphinais M, Pan SJ, Thulasingam M, Horsburgh CR, Sarkar S, Hochberg NS, Sabin LL, Flynn D, Kumar B, Sinha P, Singh UB. TB stigma in India: A narrative review of types of stigma, gender differences, and potential interventions. PLOS Glob Public Health. 2025; 5(9):e0005109. PMID: 40982550.

Published on 9/10/2025

Rao PS, Prakash Babu S, Ezhumalai K, Knudsen S, Ramakrishnan J, Joseph N, Cintron C, Dauphinais MR, Narasimhan PB, Salgame P, Hochberg NS, Hom DL, Heysell SK, Horsburgh CR, Ellner JJ, Sinha P, Sarkar S. Rifampin Exposure in Pregnant and Non-Pregnant Women with Tuberculosis in India. J Infect Dis. 2025 Sep 10. PMID: 40925610.

Published on 9/10/2025

Sinha P, Karoly M, Padmapriyadarsini C, Paradkar M, Mave V, Gupte N, Gupta A, Dauphinais M, Babu SP, Gaikwad S, Cox SR, Golub J, Cintron C, Thangakunam B, Ezhumalai K, Ponnuraja C, Tornheim JA, Christopher DJ, Viswanathan V, Ellner JJ, Kornfeld H, Horsburgh CR, Bala Yogendra Shivakumar SV, Salgame P, Bollinger RC, Sarkar S, Gupte AN. Contribution of Key Comorbidities to Unfavorable Treatment Outcomes Among Adults With Drug-sensitive Pulmonary TB in India: A Prospective Cohort Analysis. Chest. 2025 Sep 10. PMID: 40939932.

Published on 9/8/2025

Coleman M, Coussens AK, Calderwood CJ, Schoeman I, Bhargava M, Sinha P, Marais BJ, Kranzer K. Taxes for tuberculosis: could tobacco and sugar tax revenue fund tuberculosis control interventions? BMJ Glob Health. 2025 Sep 08; 10(9). PMID: 40921613.

Published on 8/29/2025

Martins MF, Teran Plasencia JM, Jacobson KR, Bouton TC, Traber KE, Canning M, Bourque DL, Sabharwal V, Michaud R, Sinha P, Acuña-Villaorduña CJ. Rifampin versus isoniazid completion rates for TB infection. Int J Tuberc Lung Dis. 2025 Aug 29; 29(9):425-427. PMID: 40883884.

Published on 8/20/2025

Sinha P, Bhargava M, Dauphinais MR, Carwile ME, Horsburgh CR, Singh UB, Sarkar S, Bhargava A, Menzies NA. In-kind Nutritional Supplementation for Persons With Drug-susceptible Tuberculosis and Their Household Contacts Would be Cost-effective for Reducing Tuberculosis Incidence and Mortality in Jharkhand, India: A Modeling Study. Clin Infect Dis. 2025 Aug 20. PMID: 40833109.

Published on 8/8/2025

Wang X, Harper K, Sinha P, Johnson WE, Patil P. Response to "Correspondence on 'Analysis of the cross-study replicability of tuberculosis gene signatures using 49 curated human transcriptomic datasets'". Tuberculosis (Edinb). 2025 Sep; 154:102678. PMID: 40816961.

Published on 7/16/2025

Kumar R, Sinha P, Krishnan A, Singh M, Singh A, Guleria R, Singh UB. Energy dense nutritional supplements improve weight gain among malnourished adults with drug-sensitive pulmonary tuberculosis: an open-label randomized controlled trial in Faridabad, India. medRxiv. 2025 Jul 16. PMID: 40791711.

View full list of 75 publications.